Methyl 3-amino-5-bromobenzo[b]thiophene-2-carboxylate

Catalog No. :
ACOEXB075
CAS No. :
1036380-75-2
Molecular Formula :
C10H8BrNO2S
Molecular Weight :
286.15

IUPAC Name:methyl 3-amino-5-bromobenzo[b]thiophene-2-carboxylate

Methyl 3-amino-5-bromobenzo[b]thiophene-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$164.00Login to see priceIn stockInquiry
25g98%$779.00Login to see priceInquiryInquiry
100g98%$2773.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-amino-5-bromobenzo[b]thiophene-2-carboxylate
IUPAC Namemethyl 3-amino-5-bromobenzo[b]thiophene-2-carboxylate
MDL No.MFCD13689055
Molecular FormulaC10H8BrNO2S
Molecular Weight286.15
SMILESO=C(C1=C(N)C2=CC(Br)=CC=C2S1)OC
InChI KeyWJWGIMBQYSUCBO-UHFFFAOYSA-N
SynonymWJWGIMBQYSUCBO-UHFFFAOYSA-N | Methyl3-amino-5-bromobenzo[b]thiophene-2-carboxylate | MFCD13689055 | FT-0717436 | SCHEMBL2063949 | 3-Amino-5-bromo-benzo[b]thiophene-2-carboxylic acid methyl ester | DTXSID70659286 | methyl 3-amino-5-bromo-1-benzothiophene-2
CAS No.1036380-75-2
PubChem CID44542789

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACOEXB075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTPOY204 route compound structure diagram
    ACTPOY204179897-89-3 In Stock
  4. Then
  5. ACOEXB075 route product structure diagram
    ACOEXB0751036380-75-2 In Stock
Inquiry

2. ACOEXB075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOEXB075 route product structure diagram
    ACOEXB0751036380-75-2 In Stock
Inquiry

Comments (0)